Evotec SE (EVTA.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 12:20PM CEST. Market open.
| Previous close | 4.9200 |
| Open | 6.9500 |
| Bid | 3.9400 x N/A |
| Ask | 5.6500 x N/A |
| Day's range | 4.8000 - 5.0500 |
| 52-week range | 4.5800 - 12.2000 |
| Volume | |
| Avg. volume | 16 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Evotec Full Year 2023 Earnings: EPS Misses Expectations
Evotec ( ETR:EVT ) Full Year 2023 Results Key Financial Results Revenue: €781.4m (up 4.0% from FY 2022). Net loss...
PR NewswireEVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis.
Simply Wall St.Evotec (ETR:EVT shareholders incur further losses as stock declines 3.7% this week, taking three-year losses to 59%
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
© 2024 Yahoo. All rights reserved.